Top results
19 september 2013 ema/chmp/578779/2013 committee for medicinal products for human use (chmp) assessment report xofigo common name: radium-223 dichloride procedure no. emea/h/c/002653/0000…
therapeutic use of xofigo® procedure checklist please see important safety information on next page and accompanying full prescribing information for further information…
dose calibrator dial setting procedure for xofigoplease see important safety information on next page and accompanying full prescribing information.for further information,…
19 september 2013 emachmp5787792013 committee for medicinal products for human use chmp assessment report xofigo common name: radium-223 dichloride procedure no emeahc0026530000…
xofigo® page 1 of 29 product monograph xofigo® radium ra 223 dichloride solution for injection 1100 kbqml 297 microcurieml radium-223 dichloride at reference date therapeutic…
nouveautÉs en mÉdecine nuclÉaire yvan boucher b sc. , m sc. md, frcp(c) service de médecine nucléaire cisssrn xofigo ( radium 223 ) psma ( antigène membranaire…
10/9/2015 1 skeletal metastases therapy: the curies’ radium george h. hinkle,rph,ms,bcnp,fashp,fapha emeritus professor the ohio state university learning objectives •…
australian public assessment report for radium 223ra dichloride proprietary product name: xofigo sponsor: bayer australia ltd july 2014 therapeutic goods administration about…
ipet 2015 – vienna – jürgen gay, bayer bhc - gcpd radiopharm safe handling of alpha emitting radiopharmaceuticals radium-223 dichloride, xofigo ipet 2015, vienna jürgen…
cancer therapy: preclinical radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models mari i suominen1…
clinical trial a phase iia, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease robert coleman • anne-kirsti aksnes…
effect of radium-223 dichloride ra-223 on hospitalisation: an analysis from the phase 3 randomised alpharadin in symptomatic prostate cancer patients alsympca trial parker…
mechanistic modelling of radium-223 treatment of bone metastases moreira h m r guerra liberal f d c osullivan j m mcmahon s j prise k m 2018 mechanistic modelling of radium-223…
attachment 1. product information for radium (223ra) dichloride attachment 1: product information for auspar xofigo radium (223ra) dichloride bayer australia ltd pm-2013-00738-1-2…
cancer therapy: preclinical radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models mari i suominen1…
timing and optimization of radium 223 in crpc disclosures • bayer • janssen objectives • significance of bone metastases • symptoms associated with bone mets •…
radium-223 the role in the mcrpc landscape department of radiation oncology and experimental cancer research @piet_ost mail: [email protected] conflict of interests type…
radium-223 in the treatment sequencing of mcrpc diogo assed bastos genitourinary oncology disclosures • honoraria: bayer, roche, msd, novartis, janssen, astellas. • research…
4th international nuclear chemistry congress, maresias, san paulo-brazil, september 14 - 19, 2014 recovery of actinium-225 and radium-223 from natural thorium irradiated…
medical use of radium-223 chloride: regulatory and technical g y considerations pat zanzonico, phd acmui radiobiology • compelling rationale for tx of skeletal metastases…